2022 – An Australian company supplies baby food to the shortage-affected United States | Baby food shortage in the United States

An Australian company plans to ship at least 1.25 million cans of baby formula to the United States to help alleviate shortages across the country.

The FDA said some of this is now available for shipment and more will be produced by Bubs Australia in the coming weeks and months.

It is the latest measure the United States is taking to address a shortage that has left many parents feeding their children after Abbott Laboratories, the country’s largest manufacturer, issued a nationwide recall.

President Joe Biden tweeted “the good news” over the weekend, saying the equivalent of 27.5 million bottles of baby formula is on the way.

“We’re doing everything we can to get more formula off the shelves as quickly as possible,” he said.

In a statement on its website, Bubs Australia has reassured Australian customers that baby food supplies will not be affected.

“Because of our tight control over the security of our supply chain and 100% manufacturing facility, we have already manufactured what is needed and have been able to take steps to increase our future production level immediately if needed,” the company said. .

She noted that the US Food and Drug Administration’s decision to allow the six Bubs Australia products to be imported and sold in the United States preceded a comprehensive review, finding that they were “safe, clean and nutritious for American children.”

The company said the US Department of Health and Human Services said it was “evaluating options” to bring Bubs infant formula products into the United States “as soon as possible.”

The import of Bubs’ products comes after some regulations were relaxed this month to alleviate one of the biggest baby food shortages in recent history. The Biden administration has also decided to import emergency supplies from Europe, the first of which arrived this week.

The shortage stems in part from Abbott Laboratories’ Michigan manufacturing facility recalling some products, including Similac, in February. Abbott said Tuesday it plans to resume production at the facility on June 4, adding that it will prioritize EleCare manufacturing and shipping on or around June 20.

The FDA said this month that it would have no “objection” to the release of about 300,000 cans of the amino acid-based Elicare infant formula previously made at Abbott Nutrition’s facility in Sturgis, Michigan. Products will undergo “enhanced microbiological testing” prior to release.

The FDA said: “Although some EleCare products have been included in Abbott Nutrition’s infant formula recalls, the EleCare products launched were in different batches, never released, and stored under the control of Abbott Nutrition. “.

Food and Drug Administration Commissioner Robert M. Califf said authorities are doing everything they can to ensure adequate infant formula is available across the country. “Our recent moves will help further enhance the supply of infant formula, including by importing safe and nutritious products from abroad based on our increased flexibility,” Califf said.

“Importantly, as a result of ongoing discussions with manufacturers and suppliers around the world, we anticipate that additional infant formula products can be imported safely and quickly into the United States in the near future.”

The US Department of Health and Human Services has also allowed global soft-goods trader Cargill Inc to provide goods needed to maximize infant formula production by invoking the Defense Production Act.

The ministry said Cargill is supplying dozens of products to infant formula makers, and the move will allow manufacturers to produce at full capacity to address an “urgent shortage in the market.”